p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.

por Honda, K., Sbisà, E., Tullo, A., Papeo, P. A., Saccone, C., Poole, S., Pignatelli, M., Mitry, R. R., Ding, S., Isla, A., Davies, A., Habib, N. A.
Publicado 1998